Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/EMCURE stock hub

NSE/EMCURE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/EMCUREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

311.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/EMCURE

In the news

Latest news · NSE/EMCURE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.2

P25 24.9P50 32.4P75 45.7

Trailing P/E33.7

P25 24.8P50 35.9P75 56.9

ROE19.6

P25 6.3P50 13.6P75 18.1

ROIC16.4

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/EMCURE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

INR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	6,731
Employees Change	-3,956%
Employees Change Percent	-37.02
Enterprise value	INR 325.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE168P01015
Last refreshed	2026-05-10
Market cap	INR 311.5B
Price	INR 1,646
Price currency	INR
Rev Per Employee	13,692,176.5x
Sector	Healthcare
Sic	2834
Symbol	nse/EMCURE
Website	https://www.emcure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.97%
EV Earnings	35.21x
EV/EBIT	23.48x
EV/EBITDA	18.07x
EV/FCF	55.83x
EV/Sales	3.53x
FCF yield	1.87%
Forward P/E	27.22x
P/B ratio	6.26x
P/E ratio	33.69x
P/S ratio	3.38x
PEG ratio	1.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.04%
EBITDA Margin	19.54%
FCF margin	6.33%
Gross margin	60.32%
Gross Profit	INR 55.6B
Gross Profit Growth	18.95%
Gross Profit Growth Q	28.08%
Gross Profit Growth3 Y	14.87%
Gross Profit Growth5 Y	64.48%
Net Income	INR 9.2B
Net Income Growth	35.67%
Net Income Growth Q	28.81%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	20.22%
Pretax Margin	13.97%
Profit Margin	10.03%
Profit Per Employee	INR 1.4M
Profitable Years	2
ROA	9.71
Roa5y	9.13
ROCE	24.32
ROE	19.57
Roe5y	22.2
ROIC	16.38
Roic5y	16.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.38%
EPS Growth	33.89
EPS Growth Q	28.79
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	18.35
FCF Growth	-7.45%
FCF Growth3 Y	17.84%
OCF Growth	10.78%
OCF Growth3 Y	8.1%
OCF Growth5 Y	50.27%
Revenue Growth	16.72x
Revenue Growth Q	16.89x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	15.47x
Revenue Growth5 Y	61.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.03
Assets	INR 96.1B
Cash	INR 1.5B
Current Assets	INR 56.1B
Current Liabilities	INR 39.1B
Debt	INR 15.2B
Debt EBITDA	INR 0.84
Debt Equity	INR 0.31
Debt FCF	INR 2.61
Equity	INR 49.8B
Interest Coverage	9.65
Liabilities	INR 46.4B
Long Term Assets	INR 40B
Long Term Liabilities	INR 7.2B
Net Cash	INR -13.7B
Net Cash By Market Cap	INR -4.41
Net Debt EBITDA	INR 0.76
Net Debt Equity	INR 0.28
Net Debt FCF	INR 2.36
Tangible Book Value	INR 38.5B
Tangible Book Value Per Share	INR 203

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.43
Inventory Turnover	1.67
Net Working Capital	INR 25.6B
Quick ratio	0.71
Working Capital	INR 17B
Working Capital Turnover	INR 5.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.33%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 3
Dividend Years	1
Dividend Yield	0.18%
Last Dividend	INR 3
Payout Ratio	6.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.33%
200-day SMA	1,449.2
50-day SMA	1,562
50-day SMA vs 200-day SMA	50over200
All Time High	1,830
All Time High Change	-10.05%
All Time High Date	2026-05-05
All Time Low	889
All Time Low Change	85.15%
All Time Low Date	2025-04-07
ATR	78.03
Beta1y	0.22
Beta2y	0.36
Ch YTD	20.63
High	1,675
High52	1,830
High52 Date	2026-05-05
High52ch	-10.05%
Low	1,630
Low52	983
Low52 Date	2025-05-09
Low52ch	67.45%
Ma50ch	5.38%
Price vs 200-day SMA	13.58%
RSI	51.5
RSI Monthly	57.86
RSI Weekly	62.3
Sharpe ratio	1.4x
Sortino ratio	2.68
Total Return	-1.15%
Tr YTD	20.63
Tr1m	5.86%
Tr1w	-8.21%
Tr3m	8.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 13.9B
Operating Income Growth	27.79
Operating Income Growth Q	30.75
Operating Income Growth3 Y	14.59
Operating Income Growth5 Y	63.57
Operating margin	15.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41,617,417%
Net Borrowing	4,884,270,000
Shares Insiders	70.4%
Shares Institutions	9.29%
Shares Out	189,589,547
Shares Qo Q	-0.01%
Shares Yo Y	1.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 5.8B
Average Volume	380,913.2x
Bv Per Share	261.1
CAPEX	INR -3.6B
Ch1m	5.86
Ch1w	-8.21
Ch1y	61.99
Ch3m	8.6
Ch6m	20.82
Change	-1.13%
Change From Open	-1.73
Close	1,664.8
Days Gap	0.61
Depreciation Amortization	4,150,460,000
Dollar Volume	433,174,528
Earnings Date	2026-05-05
EBIT	INR 13.9B
EBITDA	INR 18B
EPS	INR 48.77
F Score	6
FCF	INR 5.8B
FCF EV Yield	1.79x
FCF Per Share	INR 30.75
Financing CF	3,434,310,000
Fiscal Year End	March
Founded	1,981
Goodwill	4,142,590,000
Graham Number	535.29254
Graham Upside	-67.48
Income Tax	INR 3.5B
Investing CF	-11,930,550,000
Is Primary Listing	1
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	INR 986
Lynch Upside	-40.09
Ma150	1,466.8
Ma150ch	12.22%
Ma20	1,648.1
Ma20ch	-0.13%
Net CF	1,120,760,000
Open	1,675
P FCF Ratio	53.43
P OCF Ratio	33.01
Payment Date	2025-09-27
Position In Range	35.56
Ppne	24,908,220,000
Price Date	2026-05-08
Price EBITDA	INR 17.29
Ptbv Ratio	8.09
Relative Volume	0.7x
Revenue	92,162,040,000x
SBC By Revenue	0.03x
Share Based Comp	28,290,000
Tax By Revenue	3.75x
Tax Rate	26.87%
Tr6m	20.82%
Volume	263,168

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/EMCURE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$3.00 annual per share

Payout ratio

+6.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-1.2%

Dividend yield + buyback yield combined

Performance

NSE/EMCURE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/EMCURE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.3%

Share of float held by funds and institutions

Insider ownership

+70.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.3%

Negative means the company is buying back shares.

Technical

NSE/EMCURE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.5

Neutral momentum band

Price vs 200-day MA

+13.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/EMCURE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/EMCURE stock rating?

nse/EMCURE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/EMCURE analysis?

The full report lives at /stocks/nse/EMCURE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/EMCURE?

The latest report frames nse/EMCURE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/EMCURE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.